Endocrinology (all articles) | Page 53 of 89 | Links Medicus Content Curation & Alerts in Medicine

Vitamin D supplementation was not associated with all-cause mortality, cardiovascular mortality, or non-cancer, non-cardiovascular mortality. However, Vitamin D supplementation statistically significantly reduced the risk of cancer death by 16%.

Related Commentary on Twitter

Vitamin D supplementation alone was not associated with all cause mortality in adults compared with placebo or no treatment. However, it was associated with a reduced risk of cancer mortality by 16%, finds #BMJResearch https://t.co/jc4Tdxl6Bb

— The BMJ (@bmj_latest) August 12, 2019

[Abstract Only] Study: Diabetes Being Overtreated in Many Vulnerable Clinically Complex Adults

16 Aug, 2019 | 07:50h | UTC

Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes – Mayo Clinic Proceedings (link to abstract – $ for full-text)

Commentary: Too Much of a Good Thing Can Be Dangerous, Finds Researchers Investigating Hypoglycemia – Mayo Clinic (free)

ADA Guideline Synopsis: Diabetes Technology

13 Aug, 2019 | 08:00h | UTC

Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes – Annals of Internal Medicine (free)

Original Guideline: ADA 2019 Standards of Medical Care in Diabetes (free)

[Abstract Only] Observational Study Links Bariatric Surgery to Lower Mortality but Higher Risk of Adverse Events

13 Aug, 2019 | 05:51h | UTC

Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort study – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)

Commentary: Death Risk Drops After Bariatric Surgery in Obese Patients – MedPage Today (free registration required)

Related Research: Association of Bariatric Surgery vs Usual Care Obesity Management With All-Cause Mortality (free study and commentaries)

Related Commentary on Twitter

Long-term adverse events after #sleeve #gastrectomy or #gastric #bypass: a 7-year nationwide, observational, population-based, cohort study https://t.co/yRJg3y1SUp #bariatricsurgery pic.twitter.com/KP6u5cQWf6

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) August 8, 2019

[Abstract Only] Diabetes Subgroups Have Different Risk of Diabetes-associated Diseases

13 Aug, 2019 | 05:53h | UTC

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study – The Lancet Diabetes & Endocrinology (link to abstract and commentaries)

Commentaries: Different diabetes phenotypes associated with varying prevalence of complications – ACP Diabetes (free) AND Cluster analysis may help to predict diabetic complications – medwire News (free)

Related Study: Novel subgroups of adult-onset diabetes and their association with outcomes (link to abstract and commentaries)

Related Commentary on Twitter

What is the risk of diabetes-associated diseases in #subgroups of patients with recent-onset #diabetes? Find out in this 5-year follow-up study https://t.co/ZPYUv4IsQd #clusters #PrecisionMedicine #NAFLD #diabetic #neuropathy pic.twitter.com/9VZnl3DjKj

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) August 9, 2019

Meta-Analysis: Medications that Reduce or Increase the Risk of New Onset Diabetes

11 Aug, 2019 | 22:24h | UTC

Medications Affecting the Biochemical Conversion to Type 2 Diabetes: A Systematic Review and Meta-Analysis – The Journal of Clinical Endocrinology & Metabolism (free)

“α-Glucosidase inhibitors, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, metformin, orlistat, phentermine/topiramate, and pioglitazone significantly reduced the risk of biochemical conversion to T2DM, whereas statins and nateglinide increased the risk”

Meta-Analysis: Neonatal, Infant, and Childhood Growth Following Metformin vs. Insulin Treatment for Gestational Diabetes

11 Aug, 2019 | 22:15h | UTC

Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis – PLOS Medicine (free)

Commentary: Does metformin treatment for GDM adversely affect offspring? – Univadis (free registration required)

[Abstract Only] Study: SGLT2 Inhibitors not Associated with Increased Risk of Severe Urinary Tract Infections

11 Aug, 2019 | 21:37h | UTC

Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: SGLT-2 inhibitors not associated with increased risk for severe UTIs – ACP Diabetes (free) AND SGLT2 Inhibitor Use Not Linked to Increased Risk for UTI Events – Endocrinology Advisor (free) AND SGLT-2 inhibitors not associated with increased risk for severe UTI – 2 Minute Medicine (free)

A Clinician’s Guide to Healthy Eating for Cardiovascular Disease Prevention

8 Aug, 2019 | 07:51h | UTC

A Clinician’s Guide to Healthy Eating for Cardiovascular Disease Prevention – Mayo Clinic Proceedings: Innovations, Quality & Outcomes (free)

Study: Plant‐Based Diets Are Associated with a Lower Risk of Cardiovascular Disease and All‐Cause Mortality

8 Aug, 2019 | 07:44h | UTC

Plant‐Based Diets Are Associated With a Lower Risk of Incident Cardiovascular Disease, Cardiovascular Disease Mortality, and All‐Cause Mortality in a General Population of Middle‐Aged Adults – Journal of the American Heart Association (free)

Commentaries: Eating more plant-based foods may be linked to better heart health – American Heart Association (free) AND Healthy plant-based diet tied to lowered heart risk – Reuters (free)

[Abstract Only] Study: Metformin Use Linked to Reduced Risk for Cardiovascular Death and All-cause Mortality

7 Aug, 2019 | 07:54h | UTC

Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial – Circulation (link to abstract – $ for full-text)

Commentaries: Metformin Use and CV Outcomes Among Diabetes Patients – American College of Cardiology (free) AND Support for metformin cardioprotective effect – Medicine Matters (free) AND Metformin Use Associated With Lower Death Risk in Type 2 Diabetes – Renal & Urology News (free)

Guideline: Primary Prevention of Cardiovascular Disease and T2DM in Patients at Metabolic Risk

2 Aug, 2019 | 03:03h | UTC

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society^* Clinical Practice Guideline – The Journal of Clinical Endocrinology & Metabolism (free)

Commentaries: Older adults should be regularly screened for heart disease, diabetes risk – The Endocrine Society (free) AND Why older adults need regular metabolic risk screening – Medical News Today (free)

Amiodarone and Thyroid Physiology, Pathophysiology, Diagnosis and Management

2 Aug, 2019 | 01:39h | UTC

Amiodarone and thyroid physiology, pathophysiology, diagnosis and management – Trends in Cardiovascular Medicine (free)

Observational Study: Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet

2 Aug, 2019 | 00:59h | UTC

Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet: An Observational Study of Insulin Resistant Patients in Primary Care – Nutrients (free)

Study: Development and Validation of a Prediction Model for Fat Mass in Children and Adolescents

2 Aug, 2019 | 00:42h | UTC

Development and validation of a prediction model for fat mass in children and adolescents: meta-analysis using individual participant data – The BMJ (free)

Commentary: Assessing body fat in children made simpler by new equation – St. George’s University of London (free)

[Abstract Only] Meta-Analysis: Safety and Efficacy of Testosterone for Postmenopausal Women with Low Sexual Desire Causing Distress

29 Jul, 2019 | 20:45h | UTC

Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)

Commentaries: Testosterone may significantly improve sexual function and sexual well-being in postmenopausal women – The Lancet (free) AND Testosterone can enhance libido in postmenopausal women, new research says – CNN (free)

Related Commentary on Twitter

Just online: Safety and efficacy of #testosterone for #women: a systematic review and meta-analysis of randomised controlled trial data https://t.co/xKp6RCKd0g #postmenopausal #menopause #sexual desire pic.twitter.com/wqfMGHL37T

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 26, 2019